ESC Premium Access

Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis

Congress Presentation

About the speaker

Mr Daisuke Ueshima

Kameda Medical Center, Chiba (Japan)
0 follower

6 more presentations in this session

Safety, feasibility and performance of Valvosoft non-invasive ultrasound therapy in patients with severe symptomatic calcific aortic valve stenosis. First-in-Man

Speaker: Professor E. Messas (Paris, FR)

Thumbnail

Association between prosthesis geometry and leaflet thrombosis following transcatheter aortic valve replacement

Speaker: Doctor H. Rashid (Melbourne, AU)

Thumbnail

Temporal trends in readmissions after transcatheter aortic valve replacement

Speaker: Mr M. Hendrickson (Chapel Hill, US)

Thumbnail

Age-related clinical and hemodynamic outcome following transcatheter aortic valve replacement: a swiss TAVI registry analysis.

Speaker: Doctor A. Attinger (Fribourg, CH)

Thumbnail

Six-month and one-year outcomes with the PASCAL transcatheter valve repair system for patients with mitral regurgitation from the multicentre, prospective CLASP study

Speaker: Doctor K. Spargias (Athens, GR)

Thumbnail

Access the full session

New Insights into Percutaneous Treatments of Valvular Disease

Speakers: Mr D. Ueshima, Professor E. Messas, Doctor H. Rashid, Mr M. Hendrickson, Doctor A. Attinger...
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb